Genmab A/S (NASDAQ:GMAB) Receives Consensus Rating of “Moderate Buy” from Brokerages
Genmab A/S (NASDAQ:GMAB – Get Free Report) has received an average rating of “Moderate Buy” from the twelve ratings firms that are currently covering the stock, Marketbeat reports. Four research analysts have rated the stock with a hold recommendation, seven have assigned a buy recommendation and one has issued a strong buy recommendation on the […]
Genmab A/S (NASDAQ:GMAB – Get Free Report) has received an average rating of “Moderate Buy” from the twelve ratings firms that are currently covering the stock, Marketbeat reports. Four research analysts have rated the stock with a hold recommendation, seven have assigned a buy recommendation and one has issued a strong buy recommendation on the […]
